A carregar...
Publicação
Potential leveraged buyout of dermapharm holding se: company overview
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.98 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
The following paper focuses on the development of an investment thesis and a respective value creation strategy for the potential leveraged buyout of Dermapharm Holding
SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. It evaluates the historic financials, the business model with a
focus on what differentiates the company from the competition and an analysis on the growth and profitability mix and operational performance.
Descrição
Palavras-chave
Private equity challenge Corporate finance Private equity Capital structure Leveraged buyout Field lab Company overview Dermapharm se holding Specialty pharmaceuticals & generics